PPARγ in swim bladder development. A: Representative morphology and ORO staining of sibling 5dpf chd7+/+ (vehicle treated) and B: BADGE treated larvae with close up of caudal vein region C: ORO staining showing neutral lipid droplet accumulation in the eye vasculature and swim bladder (arrows) of 5dpf chd7+/+(vehicle treated), chd7−/− mutants and BADGE treated chd7+/+ larvae. D: Representative morphology and ORO staining of 5dpf chd7+/+ and (E) chd7−/− mutants larvae treated with RGZ, with a close-up of the caudal vein region. A–E: representative images for 3 independent experiments (n = 5larvae per condition and genotype). F. RT-qPCR of key swim bladder lipid metabolism markers fabp7b, elov1a, anxa5b and cebpa in chd7+/+ (vehicle-treated), early and late onset BADGE-treated and RGZ-treated larvae. RT-qPCR were performed with sibling wildtype (chd7+/+) larvae of 3 separate clutches (N) (N = 3 from 15 pooled fish per sample/genotype; significance: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; Error bars represent SD).
|